Cargando…

Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study

PURPOSE: As a rare type of tumor, the metastasis pattern of large cell neuroendocrine carcinoma (LCNEC) is still unclear. Our aim was to investigate metastatic patterns and develop a predictive model of prognosis in patients with advanced LCNEC. METHODS: Patients of LCNEC diagnosed between 2010–2015...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Tongchao, Sun, Haishuang, Li, Na, Jiang, Tongcui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590330/
https://www.ncbi.nlm.nih.gov/pubmed/37498395
http://dx.doi.org/10.1007/s00432-023-04975-w
_version_ 1785123968530776064
author Jiang, Tongchao
Sun, Haishuang
Li, Na
Jiang, Tongcui
author_facet Jiang, Tongchao
Sun, Haishuang
Li, Na
Jiang, Tongcui
author_sort Jiang, Tongchao
collection PubMed
description PURPOSE: As a rare type of tumor, the metastasis pattern of large cell neuroendocrine carcinoma (LCNEC) is still unclear. Our aim was to investigate metastatic patterns and develop a predictive model of prognosis in patients with advanced LCNEC. METHODS: Patients of LCNEC diagnosed between 2010–2015 from the Surveillance, Epidemiology and End Results (SEER) database were retrospectively included. Chi-square test was used for baseline characteristics analysis. Survival differences were assessed using Kaplan–Meier curves. Independent prognostic factors identified by multivariate Cox proportional risk model were used for the construction of nomogram. RESULTS: 557 eligible patients with metastasis LCNEC (median (IQR), 64 (56 to 72) years; 323 males) were included in this research. Among patients with isolated metastases, brain metastases had the highest incidence (29.4%), and multisite metastases had worse OS (HR: 2.020: 95% CI 1.413–2.888; P < 0.001) and LCSS (HR: 2.144, 95% CI 1.480–3.104; P < 0.001) in all age groups. Independent prognostic indicators including age, race, T stage, N stage, chemotherapy, radiotherapy and metastatic site were used for the construction of nomogram. Concordance index (C-index) and decision-curve analyses (DCAs) showed higher accuracy and net clinical benefit of nomogram compared to the 7th TNM staging system (OS: 0.692 vs 0.555; P < 0.001; LCSS: 0.693 vs 0.555; P < 0.001). CONCLUSIONS: We firstly established a novel comprehensive nomogram to predict the prognosis of metastasis LCNEC. The prognostic model demonstrated excellent accuracy and predictive performance. Chemotherapy and metastasis pattern were the two strongest predictive variables. Close follow-up of patients with LCNEC is necessary to make individualized treatment decisions according to different metastasis patterns. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04975-w.
format Online
Article
Text
id pubmed-10590330
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-105903302023-10-23 Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study Jiang, Tongchao Sun, Haishuang Li, Na Jiang, Tongcui J Cancer Res Clin Oncol Research PURPOSE: As a rare type of tumor, the metastasis pattern of large cell neuroendocrine carcinoma (LCNEC) is still unclear. Our aim was to investigate metastatic patterns and develop a predictive model of prognosis in patients with advanced LCNEC. METHODS: Patients of LCNEC diagnosed between 2010–2015 from the Surveillance, Epidemiology and End Results (SEER) database were retrospectively included. Chi-square test was used for baseline characteristics analysis. Survival differences were assessed using Kaplan–Meier curves. Independent prognostic factors identified by multivariate Cox proportional risk model were used for the construction of nomogram. RESULTS: 557 eligible patients with metastasis LCNEC (median (IQR), 64 (56 to 72) years; 323 males) were included in this research. Among patients with isolated metastases, brain metastases had the highest incidence (29.4%), and multisite metastases had worse OS (HR: 2.020: 95% CI 1.413–2.888; P < 0.001) and LCSS (HR: 2.144, 95% CI 1.480–3.104; P < 0.001) in all age groups. Independent prognostic indicators including age, race, T stage, N stage, chemotherapy, radiotherapy and metastatic site were used for the construction of nomogram. Concordance index (C-index) and decision-curve analyses (DCAs) showed higher accuracy and net clinical benefit of nomogram compared to the 7th TNM staging system (OS: 0.692 vs 0.555; P < 0.001; LCSS: 0.693 vs 0.555; P < 0.001). CONCLUSIONS: We firstly established a novel comprehensive nomogram to predict the prognosis of metastasis LCNEC. The prognostic model demonstrated excellent accuracy and predictive performance. Chemotherapy and metastasis pattern were the two strongest predictive variables. Close follow-up of patients with LCNEC is necessary to make individualized treatment decisions according to different metastasis patterns. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04975-w. Springer Berlin Heidelberg 2023-07-27 2023 /pmc/articles/PMC10590330/ /pubmed/37498395 http://dx.doi.org/10.1007/s00432-023-04975-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Jiang, Tongchao
Sun, Haishuang
Li, Na
Jiang, Tongcui
Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study
title Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study
title_full Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study
title_fullStr Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study
title_full_unstemmed Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study
title_short Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study
title_sort metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590330/
https://www.ncbi.nlm.nih.gov/pubmed/37498395
http://dx.doi.org/10.1007/s00432-023-04975-w
work_keys_str_mv AT jiangtongchao metastasispatternandprognosisoflargecellneuroendocrinecarcinomaapopulationbasedstudy
AT sunhaishuang metastasispatternandprognosisoflargecellneuroendocrinecarcinomaapopulationbasedstudy
AT lina metastasispatternandprognosisoflargecellneuroendocrinecarcinomaapopulationbasedstudy
AT jiangtongcui metastasispatternandprognosisoflargecellneuroendocrinecarcinomaapopulationbasedstudy